Glucosylceramide synthase inhibition with venglustat in classic fabry disease patients leads to progressive reduction of endothelial cell globotriaosylceramide inclusion volume

Category Primary study
JournalJournal of the American Society of Nephrology
Year 2020
This article has no abstract
Epistemonikos ID: 9145468adeb4dd846b6769ed1e99cedb061e41d8
First added on: Feb 12, 2025